1 |
Aller EEJG, Abete I, Astrup A, Martinez JA, van Baak MA. 2011. Starches, sugars and obesity. Nutrients 3: 341-369.
DOI
|
2 |
Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. 2010. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabe tes care 33: 2477-2483.
DOI
ScienceOn
|
3 |
Basaranoglu M, Basaranoglu G, Sabuncu T, Senturk H. 2013. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 19: 1166-1172.
DOI
ScienceOn
|
4 |
Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D'Agostino RB, Gaziano JM, Vasan RS. 2007. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 116: 480-488.
DOI
ScienceOn
|
5 |
Yoshida M, McKeown NM, Rogers G, Meigs JB, Saltzman E, D'Agostino R, Jacques PF. 2007. Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J Nutr 137: 2121-2127.
DOI
|
6 |
Ludwig DS, Peterson KE, Gortmaker SL. 2001. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357: 505-508.
DOI
ScienceOn
|
7 |
Bray GA. 2010. Soft drink consumption and obesity: it is all about fructose. Curr Opin Lipidol 21: 51-57.
DOI
ScienceOn
|
8 |
Nseir W, Nassar F, Assy N. 2010. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroentero 16: 2579-2588.
DOI
|
9 |
Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. 2009. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 51: 918-924.
DOI
ScienceOn
|
10 |
Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. 2008. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48: 993-999.
DOI
ScienceOn
|
11 |
Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM. 2010. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51: 1961-1971.
DOI
ScienceOn
|
12 |
Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. 2009. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322-1334.
DOI
ScienceOn
|
13 |
Vos MB, Lavine JE. 2013. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 57: 2525-2531.
DOI
ScienceOn
|
14 |
Almeda-Valdes P, Cuevas-Ramos D, Aguilar-Salinas CA. 2009. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol 8: S18-S24.
|
15 |
Day CP, James OF. 1998. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
DOI
ScienceOn
|
16 |
Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LM. 2011. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol 50: 1035-1043.
DOI
ScienceOn
|
17 |
Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. 2011. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93: 1048-1052.
DOI
|
18 |
Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS. 2013. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 309: 63-70.
DOI
ScienceOn
|
19 |
Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, Chiavaroli L, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Kendall CW, Jenkins DJ. 2012. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 156: 291-304.
DOI
ScienceOn
|
20 |
Rippe JM, Angelopoulos TJ. 2013. Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know? Adv Nutr 4: 236-245.
DOI
ScienceOn
|
21 |
Sclafani A, Ackroff K. 2012. Flavor preferences conditioned by intragastric glucose but not fructose or galactose in C57BL/6J mice. Physiol Behav 106: 457-461.
DOI
ScienceOn
|
22 |
Foster-Powell K, Miller JB. 1995. International tables of glycemic index. Am J Clin Nutr 62: 871S-890S.
DOI
|
23 |
Tappy L, Le KA. 2010. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90: 23-46.
DOI
ScienceOn
|
24 |
Cusi K. 2009. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 16: 141-149.
DOI
|
25 |
Thorburn AW, Crapo PA, Griver K, Wallace P, Henry RR. 1990. Long-term effects of dietary fructose on carbohydrate metabolism in non-insulin-dependent diabetes mellitus. Metabolism 39: 58-63.
DOI
ScienceOn
|
26 |
Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA. 2005. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45: 1012-1018.
DOI
ScienceOn
|
27 |
Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Tomita S, Sekiya M, Hasty A, Nakagawa Y, Sone H, Toyoshima H, Ishibashi S, Osuga J, Yamada N. 2004. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 53: 560-569.
DOI
ScienceOn
|
28 |
Bantle JP, Raatz SK, Thomas W, Georgopoulos A. 2000. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 72: 1128-1134.
DOI
|
29 |
Maersk M, Belza A, Stodkilde-Jorgensen H, Ringgaard S, Chabanova E, Thomsen H, Pedersen SB, Astrup A, Richelsen B. 2012. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 95: 283-289.
DOI
ScienceOn
|
30 |
Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, Keim NL, Cummings BP, Stanhope KL, Havel PJ. 2009. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 94: 1562-1569.
DOI
ScienceOn
|
31 |
Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. 2009. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50: 1094-1104.
DOI
ScienceOn
|
32 |
Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I. 2010. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298: G335-344.
DOI
|
33 |
Tilg H. 2010. The role of cytokines in non-alcoholic fatty liver disease. Dig Dis 28: 179-185.
DOI
ScienceOn
|
34 |
Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F. 2001. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34: 1158-1163.
DOI
ScienceOn
|
35 |
Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez R, Rossetti L, Gu W, Accili D. 2008. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 8: 333-341.
DOI
ScienceOn
|
36 |
Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF- function. Nature 389: 610-614.
DOI
ScienceOn
|
37 |
Tilg H, Moschen AR. 2008. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14: 222-231.
|
38 |
Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. 2009. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9: 327-338.
DOI
ScienceOn
|
39 |
Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH. 2008. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105: 9793-9798.
DOI
ScienceOn
|
40 |
Duffey KJ, Popkin BM. 2007. Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity (Silver Spring) 15: 2739-2747.
DOI
ScienceOn
|
41 |
Bray GA. 2013. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr 4: 220-225.
DOI
ScienceOn
|
42 |
Marriott BP, Olsho L, Hadden L, Connor P. 2010. Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr 50: 228-258.
DOI
ScienceOn
|
43 |
KNS. 2010. Dietary reference intakes for Koreans. The Korean Nutrition Society, Korea. p 65.
|